Home › Funds › Ishara Investments LP › MNPR
Ishara Investments LP position in MNPR
MONOPAR THERAPEUTICS INC · Health Care
Ishara Investments LP reported holding 12,000 shares of MNPR (MONOPAR THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$956K, representing 0.81% of its reported portfolio and ranking #32 among its reported holdings. Ishara Investments LP has disclosed MNPR holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Ishara Investments LP's MNPR position evolved
Ishara Investments LP first disclosed a stake in MNPR in Q2 2026 at 12,300 shares (US$1.1M). Across 2 filings, Ishara Investments LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 12,000 shares valued at US$956K — a reduction of -300 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 12.30K | $1.14M | New |
| Q3 2026 | 12.00K | $956.04K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MNPR and 13F data
MNPR (MONOPAR THERAPEUTICS INC) is a Health Care company. 73 other funds we track also report a position in MNPR — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$61.8M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$30.0M), Saturn V Capital Management LP (US$24.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MNPR
- RA CAPITAL MANAGEMENT, L.P. 667.21K sh · $61.78M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 323.75K sh · $29.98M · Q2 2026
- Saturn V Capital Management LP 312.35K sh · $24.88M · Q3 2026
- Siren, L.L.C. 270.12K sh · $21.52M · Q3 2026
- TCG Crossover Management, LLC 202.24K sh · $16.11M · Q3 2026
- ADAR1 Capital Management, LLC 179.03K sh · $14.26M · Q3 2026
- Vivo Capital, LLC 90.50K sh · $7.21M · Q3 2026
- Ikarian Capital, LLC 47.86K sh · $4.43M · Q2 2026
- Verdad Advisers, LP 8.41K sh · $669.95K · Q3 2026
More on Ishara Investments LP
FAQ
How long has Ishara Investments LP held MNPR?
Ishara Investments LP has disclosed MNPR holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Ishara Investments LP's current position in MNPR?
As of Q3 2026, Ishara Investments LP holds 12.00K shares of MNPR (MONOPAR THERAPEUTICS INC), valued at $956.04K, representing 0.81% of its reported portfolio and ranking #32.
Has Ishara Investments LP been buying or selling MNPR?
In the latest 13F filing (Q3 2026), Ishara Investments LP reduced its position in MNPR.
Which other funds hold MNPR?
Other major institutional holders of MNPR include RA CAPITAL MANAGEMENT, L.P., DEERFIELD MANAGEMENT COMPANY, L.P., Saturn V Capital Management LP, among 73 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.